Patients with allergic rhinitis have no sense of smell, which is triggered by the congestion and edema of the mucous membrane in the patient’s olfactory area. After exposure to allergenic stimuli, the patient’s nasal mucosa will become edematous and the patient will keep sneezing and running nose, which will affect the patient’s sense of smell.
In the treatment, active anti-allergy is recommended to reduce the edema of mucous membrane in the patient’s olfactory area. The commonly used clinical drug is mometasone furoate nasal spray, which can be used to rinse the nasal cavity with physiological sea saline to facilitate the reduction of mucosal edema in the olfactory area of patients, and can be added with loratadine dispersible tablets, which can effectively anti-allergy. After active treatment, when the patient’s allergic rhinitis symptoms have significantly improved, the patient’s sense of smell will also gradually improve. If necessary, the patient can go to the hospital for nasal endoscopy and CT to clarify the specific situation of the patient’s olfactory area.